Efficacy of the new P100 extracorporeal shock wave therapy device in the treatment of type IIIB chronic prostatitis/chronic pelvic pain syndrome: a sham treatment controlled, prospective clinical trial

Key Points

• Chronic pelvic pain syndrome improved significantly with the P100 therapy device, compared to sham treatment.
• Over 80% of patients reported marked relief from symptoms after treatment with P100 therapy.
• Prospective clinical trial design allowed for robust evaluation of treatment efficacy in chronic prostatitis.
• Findings suggest potential benefits of extracorporeal shock wave therapy for managing chronic pelvic pain.